Fig. 1From: Neuromyelitis optica: a pilot study of clinical presentation and status of serological biomarker AQP4 among patients admitted to a tertiary centre in NCNS, SudanOptic atrophy in a patient with NMO presented with reduce vision both eyes and lower limbs weakness, over 2 month durationBack to article page